Clinical Trial Update: PRESEPT Study: Evaluation of SEPT9 Biomarker Performance for Colorectal Cancer Screening

View source ↗

Summary

This clinical trial update reports the completed results of the PRESEPT study, which evaluated the SEPT9 DNA methylation biomarker for colorectal cancer screeni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Epigenomics, Inc | Conditions: Colorectal Cancer | Status: COMPLETED